Derya Çayır

Derya Çayır

Auto-generated profile, based on publicly available information

Derya Çayır

University of Health Sciences Türkiye, Ankara Etlik City Hospital, Clinic of Nuclear Medicine, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2007 in Helicobacter
Verified
Journal Article
Closed access
PDF file
TŞTürkölmez Şeyda
Türkölmez Şeyda
ÇDÇayır Derya
Çayır Derya
AFAydoğan Füsun
Aydoğan Füsun
KMKorkmaz Meliha
Korkmaz Meliha

1 February 2017 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
MAMine Araz
Mine Araz
DÇDerya Çayir
Derya Çayir
MEMehmet Erdoğan
Mehmet Erdoğan
BUBekir Uçan
Bekir Uçan
EÇErman Çakal
Erman Çakal
The aim of this study was to investigate the effects of thyroid diseases and regularly used medications on the sensitivity of Tc-99m methoxyisobutylisonitrile (MIBI) dual-phase parathyroid single photon emission computed tomography (SPECT) and to define indicatives of the result of the study. Overall, 218 primary hyperparathyroidism patients (190 women, 28 men, mean age: 57±14 years) with thyroid-parathyroid ultrasonography and Tc-99m MIBI dual-phase parathyroid SPECT were retrospectively enrolled. Patients were divided as follows: a positive SPECT group [119 (54.6%) patients] and a negative SPECT group [99 (45.4%) patients]. The effects of thyroid diseases and use of calcium channel blockers, β-blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, oral antidiabetics, thyroid hormone preparates, nonsteroidal anti-inflammatory drugs, and proton pump inhibitors on the sensitivity of Tc-99m MIBI dual-phase parathyroid SPECT were investigated. The frequency of NSAID usage was higher in the negative scan group (P<0.001). No significant difference was detected in terms of coexisting thyroid disease or usage of other medications. Overall sensitivity, specificity, positive, and negative predictive value of Tc-99m MIBI dual-phase parathyroid SPECT were calculated to be 89.6, 92.5, 94.1, and 86.9%. The sensitivity was low only in nonsteroidal anti-inflammatory drug users (75.6%) compared with nonusers (96.5%). Logistic regression showed that ultrasonography was indicative of a positive scan and the possibility of a negative result was increased by regular usage of nonsteroid anti-inflammatory drugs (odds ratio: 0.262, confidence interval: 0.128-0.538; P<0.001) CONCLUSION: Among various drug groups, NSAIDs may decrease the sensitivity of Tc-99m MIBI SPECT and, provided that these novel data are supported by other studies, patient preparation may be modified to stop NSAIDs before Tc-99m MIBI dual-phase parathyroid SPECT.

1 April 2018 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
DÇDerya Çayir
Derya Çayir
MAMine Araz
Mine Araz
AYAli Yalçindağ
Ali Yalçindağ
EÇErman Çakal
Erman Çakal
Objective The relationship between multiple semiquantitative indices on technetium-99m metoxyisobutylisonitrile (Tc-99m MIBI) parathyroid single-photon emission computed tomography (SPECT) and clinical, laboratory, and radiological data was investigated in primary hyperparathyroidism. Patients and methods Ninety-three patients who had a histopathologically confirmed single parathyroid adenoma (PT) were enrolled. Regions of interests were drawn around the PT, neighboring thyroid (T), and background in early and late planar images and isocontour regions of interests around the adenoma in SPECT images (PT SPECT). The relationships between early and late PT, parathyroid adenoma counts/neighboring thyroid counts, parathyroid counts-thyroid counts (PT-T), PT washout, retention index, PT SPECT and serum parathormone (PTH), Ca, P, urinary Ca levels, weight of the adenoma, neck ultrasonography, renal ultrasonography, and bone mineral density findings were investigated. Results There was a positive correlation between the weight of the adenoma and serum PTH and calcium (Ca) levels (P<0.001), between serum PTH and Ca levels (P<0.001), early PT-T and serum Ca levels (P=0.027), late PT-T and weight of the adenoma (P=0.04), and PT SPECT and serum Ca levels (P=0.046) and a reverse correlation between PT SPECT and serum phosphorus (P) levels (P=0.04). Serum Ca levels were significantly higher and P levels were lower in the group with PT SPECT values above 116. PT SPECT and late parathyroid adenoma counts/neighboring thyroid counts values were significantly higher in the group with serum Ca levels of more than 11 mg/dl. Femoral T and Z scores were significantly lower in patients with lower PT washout. Early PT was significantly lower in patients with coexisting thyroiditis compared with patients with both thyroiditis and thyroid nodules (P=0.034). Conclusion Semiquantitative evaluation of a Tc-99m MIBI parathyroid SPECT study may help predict disease severity in primary hyperparathyroidism.

11 June 2011 in Annals of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
DCDerya Cayir
Derya Cayir
KDKoray Demirel
Koray Demirel
MKMeliha Korkmaz
Meliha Korkmaz
GKGokhan Koca
Gokhan Koca

23 January 2018 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
DÇDerya Çayır
Derya Çayır
MAMine Araz
Mine Araz
MAMahmut Apaydın
Mahmut Apaydın
EÇErman Çakal
Erman Çakal
We present a rare case with inguinal iodine-131 (I-131) uptake on whole body scan. The patient was suffering from a painful right inguinal mass during menstrual period, which was later sonographically and histopathologically confirmed to be an inguinal focus of endometriosis. Endometriosis is a previously reported site of radioiodine uptake and detection of radioiodine uptake in the inguinal region has also been described. Nevertheless, to the best of our knowledge, this is the first case report of I-131 uptake in an inguinal endometriosis focus. History and physical examination of the patient are both very important in identifying the etiology of the ectopic uptake sites on I-131 whole body scan, and inguinal endometriosis should be kept in mind while reporting inguinal radioiodine uptake on I-131 whole body scan.

27 February 2017 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Open access
MAMine Araz
Mine Araz
DÇDerya Çayır
Derya Çayır
Positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (FDG) is used in staging, restaging, and evaluation of therapy response in many cancers as well as differentiated thyroid carcinomas especially in non-iodine avid variants. Its potential in less frequent thyroid tumors like medullary, anaplastic thyroid cancers, thyroid lymphoma and metastatic tumors of the thyroid however, is not well established yet. The aim of this review is to provide an overview on the recent applications and indications of 18F-FDG PET/CT in these tumors and to focus on the controversies in the clinical setting.